Defunct Company
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
424
NCT05331937
TMS for Exposure Therapy Resistant OCD
Phase: Phase 3
Role: Collaborator
Start: May 16, 2022
Completion: Sep 1, 2027
NCT06352346
A Single-case Design to Investigate a Compensatory Brain Game Supporting Goal Management Training Intervention in a Psychiatric Brain Injury Population
Phase: N/A
Role: Lead Sponsor
Start: May 31, 2024
Completion: Dec 31, 2025
NCT06770517
Exposure Therapy for Late-life Anxiety
Start: Feb 12, 2025
Completion: Dec 19, 2028